TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/12/24 16:23 | 4/10/24 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | CA | D | M.d | 36 | 16.80 | 0 | 2 | 16 | 16 | D | |||||||||||||||
4/12/24 16:23 | 4/10/24 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | CA | D | S.d | -80 | 37.00 | 0 | -2 | -12 | 16 | D | |||||||||||||||
6/15/23 21:00 | 6/13/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | MA | O | Chief St | S | -137 | 24.05 | 0 | -6 | -4 | 149 | D | ||||||||||||||
5/18/23 20:36 | 5/16/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | MA | O | Chief St | S | -281 | 18.05 | 0 | -16 | -9 | 155 | D | ||||||||||||||
5/18/22 19:01 | 5/16/22 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | MA | O | Chief Co | S | -156 | 14.59 | 0 | -11 | -8 | 130 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |